{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:34:20Z","timestamp":1793162060070,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Zhejiang Chinese Medicine University Postgraduate Scientific Research Fund Project","award":["No. 2022YKJ03"],"award-info":[{"award-number":["No. 2022YKJ03"]}]},{"name":"Discipline Construction Project of Zhejiang Chinese Medical University, the National Natural Science Foundation of China","award":["No. 81803980"],"award-info":[{"award-number":["No. 81803980"]}]},{"name":"the Research Project of Zhejiang Chinese Medical University","award":["No. 2022JKZZW03"],"award-info":[{"award-number":["No. 2022JKZZW03"]}]},{"name":"the Research Project of Zhejiang Chinese Medical University","award":["2020ZG09"],"award-info":[{"award-number":["2020ZG09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84704-6","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:17:40Z","timestamp":1735874260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis"],"prefix":"10.1038","volume":"15","author":[{"given":"Fugang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"84704_CR1","doi-asserted-by":"publisher","first-page":"632388","DOI":"10.3389\/fphar.2021.632388","volume":"12","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. Mitochondrial targeting of herbal medicine in chronic kidney disease. Front. Pharmacol. 12, 632388. https:\/\/doi.org\/10.3389\/fphar.2021.632388 (2021).","journal-title":"Front. Pharmacol."},{"key":"84704_CR2","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/ijms25031755","volume":"25","author":"TH Yeh","year":"2024","unstructured":"Yeh, T. H. et al. From acute to chronic: Unraveling the pathophysiological mechanisms of the progression from acute kidney injury to acute kidney disease to chronic kidney disease. Int. J. Mol. Sci. 25, 1755. https:\/\/doi.org\/10.3390\/ijms25031755 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"84704_CR3","doi-asserted-by":"publisher","unstructured":"Andr\u00e9, C. et al. The AKI-to-CKD transition: The role of uremic toxins. Int. J. Mol. Sci. 24, 16152. https:\/\/doi.org\/10.3390\/ijms242216152 (2023).","DOI":"10.3390\/ijms242216152"},{"key":"84704_CR4","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.3390\/jcm13092455","volume":"13","author":"C Tamargo","year":"2024","unstructured":"Tamargo, C. et al. Treatment of acute kidney injury: A review of current approaches and emerging innovations. J. Clin. Med. 13, 2455. https:\/\/doi.org\/10.3390\/jcm13092455 (2024).","journal-title":"J. Clin. Med."},{"key":"84704_CR5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/jcm9061704","volume":"9","author":"J Gameiro","year":"2020","unstructured":"Gameiro, J. et al. Acute kidney injury: From diagnosis to prevention and treatment strategies. J. Clin. Med. 9, 1704. https:\/\/doi.org\/10.3390\/jcm9061704  (2020).","journal-title":"J. Clin. Med."},{"key":"84704_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jgr.2020.08.001","volume":"45","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota. J. Ginseng Res. 45, 334\u2013343. https:\/\/doi.org\/10\/g8sh4b (2021).","journal-title":"J. Ginseng Res."},{"key":"84704_CR7","doi-asserted-by":"publisher","first-page":"12863","DOI":"10.3390\/ijms232112863","volume":"23","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Ginsenoside Compound K ameliorates development of diabetic kidney disease through inhibiting TLR4 activation induced by microbially produced imidazole propionate. Int. J. Mol. Sci. 23, 12863. https:\/\/doi.org\/10.3390\/ijms232112863 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"84704_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4049\/jimmunol.1900284","volume":"205","author":"CY Wu","year":"2020","unstructured":"Wu, C. Y. et al. IgA nephropathy benefits from compound K treatment by inhibiting NF-\u03baB\/NLRP3 inflammasome and enhancing autophagy and SIRT1. J. Immunol. 205, 202\u2013212. https:\/\/doi.org\/10.4049\/jimmunol.1900284 (2020).","journal-title":"J. Immunol."},{"key":"84704_CR9","first-page":"74","volume":"35","author":"WH Hsu","year":"2020","unstructured":"Hsu, W. H. et al. Compound K inhibits priming and mitochondria-associated activating signals of NLRP3 inflammasome in renal tubulointerstitial lesions. Nephrol. Dial Transpl. 35, 74\u201385 (2020).","journal-title":"Nephrol. Dial Transpl."},{"key":"84704_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.kint.2021.05.035","volume":"100","author":"Y Zuo","year":"2021","unstructured":"Zuo, Y. et al. Identification of matrix metalloproteinase-10 as a key mediator of podocyte injury and proteinuria. Kidney Int. 100, 837\u2013849.  https:\/\/doi.org\/10.1016\/j.kint.2021.05.035(2021).","journal-title":"Kidney Int."},{"key":"84704_CR11","doi-asserted-by":"publisher","unstructured":"Li, J. et al. Research progress on exosomes in podocyte injury associated with diabetic kidney disease. Front. Endocrinol. 14 (1129884). https:\/\/doi.org\/10.3389\/fendo.2023.1129884  (2023).","DOI":"10.3389\/fendo.2023.1129884"},{"key":"84704_CR12","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1002\/ar.24291","volume":"303","author":"W Kriz","year":"2020","unstructured":"Kriz, W. The inability of podocytes to proliferate: Cause, consequences, and origin. Anat. Rec (Hoboken). 303, 2588\u20132596. https:\/\/doi.org\/10.1002\/ar.24291 (2020).","journal-title":"Anat. Rec (Hoboken)"},{"key":"84704_CR13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1042\/CS20190764","volume":"134","author":"PA Reynolds","year":"2020","unstructured":"Reynolds, P. A. The mechanobiology of kidney podocytes in health and disease. Clin. Sci. (Lond). 134, 1245\u20131253. https:\/\/doi.org\/10.1042\/CS20190764 (2020).","journal-title":"Clin. Sci. (Lond)"},{"key":"84704_CR14","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. Podocyte injury in diabetic kidney disease: A focus on mitochondrial dysfunction. Front. Cell. Dev. Biol. 10 (832887). https:\/\/doi.org\/10.3389\/fcell.2022.832887 (2022).","DOI":"10.3389\/fcell.2022.832887"},{"key":"84704_CR15","doi-asserted-by":"publisher","unstructured":"Yu, C. J. et al. The pathophysiologic role of gelsolin in chronic kidney disease: Focus on podocytes. Int. J. Mol. Sci. 22, 13281 https:\/\/doi.org\/10.3389\/fcell.2022.832887 (2021).","DOI":"10.3389\/fcell.2022.832887"},{"key":"84704_CR16","doi-asserted-by":"publisher","unstructured":"Huang, X. et al. PFKFB3 downregulation aggravates angiotensin II-induced podocyte detachment. Ren. Fail. 45, 2230318 https:\/\/doi.org\/10.1080\/0886022X.2023.2230318 (2023).","DOI":"10.1080\/0886022X.2023.2230318"},{"key":"84704_CR17","doi-asserted-by":"publisher","unstructured":"Yin, L. et al. Controversies in podocyte loss: Death or detachment? Front. Cell Dev. Biol. 9, 771931. https:\/\/doi.org\/10.3389\/fcell.2021.771931(2021).","DOI":"10.3389\/fcell.2021.771931"},{"key":"84704_CR18","doi-asserted-by":"publisher","unstructured":"Yamamoto, K. et al. Podocytes are lost from glomeruli before completing apoptosis. Am. J. Physiol. Renal Physiol. 323, F515\u2013F526 https:\/\/doi.org\/10.1152\/ajprenal.00080.2022. (2022).","DOI":"10.1152\/ajprenal.00080.2022."},{"key":"84704_CR19","doi-asserted-by":"publisher","first-page":"119068","DOI":"10.1016\/j.lfs.2021.119068","volume":"269","author":"L Xing","year":"2021","unstructured":"Xing, L. et al. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPAR\u03b3-Klotho-FOXO1 axis in diabetic nephropathy. Life Sci. 269, 119068. https:\/\/doi.org\/10.1016\/j.lfs.2021.119068(2021).","journal-title":"Life Sci."},{"key":"84704_CR20","doi-asserted-by":"publisher","unstructured":"Cao, Y. et al. MFN2 regulates high glucose-induced MAMs dysfunction and apoptosis in podocytes via PERK pathway. Front. Cell. Dev. Biol. 9 (769213). https:\/\/doi.org\/10.3389\/fcell.2021.769213.eCollection2021 (2021).","DOI":"10.3389\/fcell.2021.769213.eCollection2021"},{"key":"84704_CR21","doi-asserted-by":"publisher","first-page":"e937766","DOI":"10.12659\/MSM.937766","volume":"28","author":"NS Erekat","year":"2022","unstructured":"Erekat, N. S Programmed cell death in diabetic nephropathy: A review of apoptosis, autophagy, and necroptosis. Med. Sci. Monit. 28, e937766.  https:\/\/doi.org\/10.12659\/MSM.937766(2022).","journal-title":"Med. Sci. Monit."},{"key":"84704_CR22","doi-asserted-by":"publisher","unstructured":"Zhu, Z. et al. Mitoquinone protects podocytes from angiotensin II-induced mitochondrial dysfunction and injury via the KEAP1-NRF2 signaling pathway. Oxid. Med. Cell Longev. 1394486 (2021). https:\/\/doi.org\/10.1155\/2021\/1394486.eCollection2021 (2021).","DOI":"10.1155\/2021\/1394486.eCollection2021"},{"key":"84704_CR23","doi-asserted-by":"publisher","unstructured":"Vida, C. et al. Oxidative stress in patients with advanced CKD and renal replacement therapy: The key role of peripheral blood leukocytes. Antioxidants (Basel) 10, 1155. https:\/\/doi.org\/10.3390\/antiox10071155 (2021).","DOI":"10.3390\/antiox10071155"},{"key":"84704_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.7150\/ijbs.89916","volume":"20","author":"T Li","year":"2024","unstructured":"Li, T. et al. Loss of MTX2 causes mitochondrial dysfunction, podocyte injury, nephrotic proteinuria and glomerulopathy in mice and patients. Int. J. Biol. Sci. 20, 937\u2013952 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"84704_CR25","doi-asserted-by":"crossref","unstructured":"Vercellino, I. et al. The assembly, regulation and function of the mitochondrial respiratory chain. Nat. Rev. Mol. Cell Biol. 23, 141\u2013161. https:\/\/doi.org\/10\/gnqvhv  (2022).","DOI":"10.1038\/s41580-021-00415-0"},{"key":"84704_CR26","doi-asserted-by":"crossref","unstructured":"Mise, K. et al. NDUFS4 regulates cristae remodeling in diabetic kidney disease. Nat. Commun. 15, 1965. https:\/\/doi.org\/10\/gtkwnw (2024).","DOI":"10.1038\/s41467-024-46366-w"},{"key":"84704_CR27","doi-asserted-by":"publisher","first-page":"720656","DOI":"10.3389\/fcell.2021.720656","volume":"9","author":"S Geldon","year":"2021","unstructured":"Geldon, S. et al. Redox-mediated regulation of mitochondrial biogenesis, dynamics, and respiratory chain assembly in yeast and human cells. Front. Cell. Dev. Biol. 9, 720656. https:\/\/doi.org\/10.3389\/fcell.2021.720656 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"84704_CR28","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.3390\/ijms24054696","volume":"24","author":"X Han","year":"2023","unstructured":"Han, X. et al. Placental mesenchymal stem cells alleviate podocyte injury in diabetic kidney disease by modulating mitophagy via the SIRT1-PGC-1\u03b1-TFAM pathway. Int. J. Mol. Sci. 24, 4696. https:\/\/doi.org\/10.3390\/ijms24054696 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"84704_CR29","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/1873-3468.14077","volume":"595","author":"NMB Yapa","year":"2021","unstructured":"Yapa, N. M. B. et al. Mitochondrial dynamics in health and disease. FEBS Lett. 595, 1184\u20131204. https:\/\/doi.org\/10.1002\/1873-3468.14077 (2021).","journal-title":"FEBS Lett."},{"key":"84704_CR30","doi-asserted-by":"publisher","unstructured":"Adebayo, M. et al. Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis. FASEB J. 35 (e21620). https:\/\/doi.org\/10.1096\/fj.202100067R (2021).","DOI":"10.1096\/fj.202100067R"},{"key":"84704_CR31","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1681\/ASN.2021101384","volume":"33","author":"S Gao","year":"2022","unstructured":"Gao, S. et al. Complement C3a and C3a receptor activation mediates podocyte injuries in the mechanism of primary membranous nephropathy. J. Am. Soc. Nephrol. 33, 1742\u20131756. https:\/\/doi.org\/10.1681\/ASN.2021101384 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"84704_CR32","doi-asserted-by":"publisher","first-page":"155247","DOI":"10.1016\/j.phymed.2023.155247","volume":"123","author":"M Gong","year":"2024","unstructured":"Gong, M. et al. Modified Hu-Lu-Ba-Wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis. Phytomedicine 123, 155247. https:\/\/doi.org\/10.1016\/j.phymed.2023.155247 (2024).","journal-title":"Phytomedicine"},{"key":"84704_CR33","doi-asserted-by":"publisher","unstructured":"Jadli, A. et al. Abstract P176: Pharmacological inhibition of DRP1-dependent mitochondrial fission alleviates mitochondrial dysfunction-associated cell death in vascular smooth muscle cells. Arterioscler. Thromb. Vasc Biol. 41 (Suppl_1). https:\/\/doi.org\/10.1161\/atvb.41.suppl_1.P176 (2021).","DOI":"10.1161\/atvb.41.suppl_1.P176"},{"key":"84704_CR34","doi-asserted-by":"publisher","first-page":"eabc7931","DOI":"10.1126\/scisignal.abc7931","volume":"14","author":"S Huang","year":"2021","unstructured":"Huang, S. et al. DDAH2 suppresses RLR-MAVS-mediated innate antiviral immunity by stimulating nitric oxide-activated, DRP1-induced mitochondrial fission. Sci. Signal. 14, eabc7931. https:\/\/doi.org\/10.1126\/scisignal.abc79 (2021).","journal-title":"Sci. Signal."},{"key":"84704_CR35","doi-asserted-by":"publisher","unstructured":"Jenner, A. et al. DRP1 interacts directly with BAX to induce its activation and apoptosis. EMBO J. 41 (e108587). https:\/\/doi.org\/10.15252\/embj.2021108587 (2022).","DOI":"10.15252\/embj.2021108587"},{"key":"84704_CR36","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.3390\/ijms22083903","volume":"22","author":"L Doblado","year":"2021","unstructured":"Doblado, L. et al. Mitophagy in human diseases. Int. J. Mol. Sci. 22, 3903. https:\/\/doi.org\/10.3390\/ijms22083903 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"84704_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/antiox13010081","volume":"13","author":"H Guo","year":"2024","unstructured":"Guo, H. et al. ADP-ribosylation factor-interacting protein 2 acts as a novel regulator of mitophagy and autophagy in podocytes in diabetic nephropathy. Antioxid. (Basel). 13, 81 (2024).","journal-title":"Antioxid. (Basel)"},{"key":"84704_CR38","doi-asserted-by":"publisher","first-page":"175136","DOI":"10.1016\/j.ejphar.2022.175136","volume":"929","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. MitoTEMPO protects against podocyte injury by inhibiting NLRP3 inflammasome via PINK1\/Parkin pathway-mediated mitophagy. Eur. J. Pharmacol. 929, 175136 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"84704_CR39","doi-asserted-by":"publisher","first-page":"e23503","DOI":"10.1002\/jbt.23503","volume":"37","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Poricoic acid a induces mitophagy to ameliorate podocyte injury in diabetic kidney disease via downregulating FUNDC1. J. Biochem. Mol. Toxicol. 37, e23503 (2023).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"84704_CR40","doi-asserted-by":"publisher","first-page":"108883","DOI":"10.1016\/j.isci.2024.108883","volume":"27","author":"Y He","year":"2024","unstructured":"He, Y. et al. Deficient tRNA posttranscription modification dysregulated the mitochondrial quality controls and apoptosis. iScience 27, 108883 (2024).","journal-title":"iScience"},{"key":"84704_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.trsl.2020.10.010","volume":"230","author":"T Khuanjing","year":"2021","unstructured":"Khuanjing, T. et al. Donepezil attenuated cardiac ischemia\/reperfusion injury through balancing mitochondrial dynamics, mitophagy, and autophagy. Transl Res. 230, 82\u201397. https:\/\/doi.org\/10.1016\/j.trsl.2020.10.010 (2021).","journal-title":"Transl Res."},{"key":"84704_CR42","doi-asserted-by":"publisher","first-page":"116050","DOI":"10.1016\/j.ecoenv.2024.116050","volume":"272","author":"T Tian","year":"2024","unstructured":"Tian, T. et al. The role of DRP1-mediated mitophagy in HT22 cell apoptosis induced by silica nanoparticles. Ecotoxicol. Environ. Saf. 272, 116050 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"84704_CR43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3892\/ijmm.2020.4797","volume":"47","author":"F Wu","year":"2021","unstructured":"Wu, F. et al. Bleomycin A5 suppresses DRP1-mediated mitochondrial fission and induces apoptosis in human nasal polyp-derived fibroblasts. Int. J. Mol. Med. 47, 346\u2013360. https:\/\/doi.org\/10.3892\/ijmm.2020.4797 (2021).","journal-title":"Int. J. Mol. Med."},{"key":"84704_CR44","doi-asserted-by":"publisher","unstructured":"Onishi, M. et al. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 40 (e104705). https:\/\/doi.org\/10.15252\/embj.2020104705 (2021).","DOI":"10.15252\/embj.2020104705"},{"key":"84704_CR45","doi-asserted-by":"publisher","first-page":"108142","DOI":"10.1016\/j.intimp.2021.108142","volume":"100","author":"M Chen","year":"2021","unstructured":"Chen, M. et al. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury. Int. Immunopharmacol. 100, 108142. https:\/\/doi.org\/10.1016\/j.intimp.2021.108142 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"84704_CR46","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1038\/s41423-021-00763-z","volume":"18","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. MHC class II in renal tubules plays an essential role in renal fibrosis. Cell. Mol. Immunol. 18, 2530\u20132540. https:\/\/doi.org\/10.1038\/s41423-021-00763-z (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"84704_CR47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ame2.12194","volume":"4","author":"LJ Yan","year":"2021","unstructured":"Yan, L. J. Folic acid-induced animal model of kidney disease. Anim. Models Exp. Med. 4, 329\u2013342. https:\/\/doi.org\/10.1002\/ame2.12194 (2021).","journal-title":"Anim. Models Exp. Med."},{"key":"84704_CR48","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1681\/ASN.2020050572","volume":"31","author":"L Ning","year":"2020","unstructured":"Ning, L. et al. Synaptopodin is dispensable for normal podocyte homeostasis but is protective in the context of acute podocyte injury. J. Am. Soc. Nephrol. 31, 2815\u20132832. https:\/\/doi.org\/10.1681\/ASN.2020050572 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"84704_CR49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1042\/CS20210625","volume":"136","author":"F Barutta","year":"2022","unstructured":"Barutta, F. et al. Mechanisms of podocyte injury and implications for diabetic nephropathy. Clin. Sci. (Lond). 136, 493\u2013520. https:\/\/doi.org\/10.1042\/CS20210625 (2022).","journal-title":"Clin. Sci. (Lond)"},{"key":"84704_CR50","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1111\/jcmm.16519","volume":"25","author":"F Tesch","year":"2021","unstructured":"Tesch, F. et al. Super-resolved local recruitment of CLDN5 to filtration slits implicates a direct relationship with podocyte foot process effacement. J. Cell. Mol. Med. 25, 7631\u20137641. https:\/\/doi.org\/10.1111\/jcmm.16519 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"84704_CR51","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ki.2009.424","volume":"77","author":"P Mundel","year":"2010","unstructured":"Mundel, P. et al. Proteinuria: An enzymatic disease of the podocyte? Kidney Int. 77, 571\u2013580. https:\/\/doi.org\/10.1038\/ki.2009.424 (2010).","journal-title":"Kidney Int."},{"key":"84704_CR52","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.kint.2020.08.035","volume":"99","author":"J Matsuda","year":"2021","unstructured":"Matsuda, J. et al. Rho GTPase regulatory proteins in podocytes. Kidney Int. 99, 336\u2013345. https:\/\/doi.org\/10.1016\/j.kint.2020.08.035 (2021).","journal-title":"Kidney Int."},{"key":"84704_CR53","doi-asserted-by":"publisher","unstructured":"Foxman, E. et al. Rho GTPase regulatory proteins contribute to podocyte morphology and function. McGill Sci. Undergrad. Res. J. 2024. https:\/\/doi.org\/10.26443\/msurj.v18i1.193 (2023).","DOI":"10.26443\/msurj.v18i1.193"},{"key":"84704_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/21541248.2021.1932402","volume":"13","author":"C Steichen","year":"2022","unstructured":"Steichen, C. et al. Rho GTPases in kidney physiology and diseases. Small GTPases. 13, 141\u2013161. https:\/\/doi.org\/10.1080\/21541248.2021.1932402 (2022).","journal-title":"Small GTPases"},{"key":"84704_CR55","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.kint.2020.12.022","volume":"99","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. Rho-GTPase activating protein myosin MYO9A identified as a novel candidate gene for monogenic focal segmental glomerulosclerosis. Kidney Int. 99, 1102\u20131117. https:\/\/doi.org\/10.1016\/j.kint.2020.12.022 (2021).","journal-title":"Kidney Int."},{"key":"84704_CR56","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1080\/15384101.2023.2289753","volume":"22","author":"NS Wu","year":"2023","unstructured":"Wu, N. S. et al. The mystery of phospho-DRP1 with four adaptors in cell cycle: When mitochondrial fission couples to cell fate decisions. Cell. Cycle. 22, 2485\u20132503. https:\/\/doi.org\/10.1080\/15384101.2023.2289753 (2023).","journal-title":"Cell. Cycle"},{"key":"84704_CR57","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1111\/cas.14662","volume":"111","author":"N Fujiwara","year":"2020","unstructured":"Fujiwara, N. et al. Autophagy regulates levels of tumor suppressor enzyme protein phosphatase 6. Cancer Sci. 111, 4371\u20134380 (2020).","journal-title":"Cancer Sci."},{"key":"84704_CR58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biochi.2020.04.025","volume":"175","author":"S Kaur","year":"2020","unstructured":"Kaur, S. et al. The beclin 1 interactome: Modification and roles in the pathology of autophagy-related disorders. Biochimie 175, 34\u201349. https:\/\/doi.org\/10.1016\/j.biochi.2020.04.025 (2020).","journal-title":"Biochimie"},{"key":"84704_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jphs.2020.11.005","volume":"145","author":"F Tian","year":"2021","unstructured":"Tian, F. et al. The ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells by regulating the RhoA\/ROCKs\/YAP signaling pathway and cytoskeleton formation. J. Pharmacol. Sci. 145, 88\u201396. https:\/\/doi.org\/10.1016\/j.jphs.2020.11.005 (2021).","journal-title":"J. Pharmacol. Sci."},{"key":"84704_CR60","doi-asserted-by":"publisher","first-page":"22676","DOI":"10.1074\/jbc.M110.122929","volume":"285","author":"P Garg","year":"2010","unstructured":"Garg, P. et al. Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture. J. Biol. Chem. 285, 22676\u201322688. https:\/\/doi.org\/10.1074\/jbc.M110.122929 (2010).","journal-title":"J. Biol. Chem."},{"key":"84704_CR61","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12964-021-00763-6","volume":"19","author":"X Li","year":"2021","unstructured":"Li, X. et al. Hhex inhibits cell migration via regulating RhoA\/CDC42-CFL1 axis in human lung cancer cells. Cell. Commun. Signal. 19, 80. https:\/\/doi.org\/10.1186\/s12964-021-00763-6 (2021).","journal-title":"Cell. Commun. Signal."},{"key":"84704_CR62","doi-asserted-by":"publisher","unstructured":"Bouslama, R. et al. Phosphorylation of PACSIN2 at S313 regulates podocyte architecture in coordination with N-WASP. Cells 12, 1487.    https:\/\/doi.org\/10.3390\/cells12111487 (2023).","DOI":"10.3390\/cells12111487"},{"key":"84704_CR63","doi-asserted-by":"publisher","unstructured":"Solanki, A. K. et al. Phosphorylation of slit diaphragm proteins nephrin and NEPH1 upon binding of HGF promotes podocyte repair. J. Biol. Chem. 297, 101079. https:\/\/doi.org\/10.1016\/j.jbc.2021.101079 (2021).","DOI":"10.1016\/j.jbc.2021.101079"},{"key":"84704_CR64","doi-asserted-by":"publisher","first-page":"e12626","DOI":"10.1371\/journal.pone.0012626","volume":"5","author":"S Ashworth","year":"2010","unstructured":"Ashworth, S. et al. Cofilin-1 inactivation leads to proteinuria\u2014studies in zebrafish, mice and humans. PLoS One. 5, e12626 (2010).","journal-title":"PLoS One"},{"key":"84704_CR65","doi-asserted-by":"publisher","unstructured":"Sousa-Squiavinato, A. C. M. et al. Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes. Cancer Cell Int. 21, 69. https:\/\/doi.org\/10.1186\/s12935-021-01770-w (2021).","DOI":"10.1186\/s12935-021-01770-w"},{"key":"84704_CR66","doi-asserted-by":"publisher","first-page":"10291","DOI":"10.18632\/aging.205075","volume":"15","author":"H Li","year":"2023","unstructured":"Li, H. et al. Dendrobium officinale polysaccharide decreases podocyte injury in diabetic nephropathy by regulating IRS-1\/AKT signal and promoting mitophagy. Aging 15, 10291\u201310306. https:\/\/doi.org\/10.18632\/aging.205075 (2023).","journal-title":"Aging"},{"key":"84704_CR67","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/antiox11071240","volume":"11","author":"J Cao","year":"2022","unstructured":"Cao, J. et al. Endoplasmic reticulum stress and reactive oxygen species in plants. Antioxid. (Basel). 11, 1240. https:\/\/doi.org\/10.3390\/antiox11071240 (2022).","journal-title":"Antioxid. (Basel)"},{"key":"84704_CR68","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/life13010098","volume":"13","author":"J He","year":"2022","unstructured":"He, J. et al. Redox regulation of autophagy in cancer: Mechanism, prevention and therapy. Life (Basel). 13, 98. https:\/\/doi.org\/10.3390\/life13010098 (2022).","journal-title":"Life (Basel)"},{"key":"84704_CR69","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12967-024-05089-8","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Caffeic acid phenethyl ester inhibits neuro-inflammation and oxidative stress following spinal cord injury by mitigating mitochondrial dysfunction via the SIRT1\/PGC1\u03b1\/DRP1 signaling pathway. J. Transl Med. 22, 304. https:\/\/doi.org\/10.1186\/s12967-024-05089-8 (2024).","journal-title":"J. Transl Med."},{"key":"84704_CR70","doi-asserted-by":"publisher","unstructured":"Deragon, M. A. et al. Mitochondrial trafficking of MLKL, BAK\/BAX, and DRP1 is mediated by RIP1 and ROS, which leads to decreased mitochondrial membrane integrity during the hyperglycemic shift to necroptosis. Int. J. Mol. Sci. 24, 8609. https:\/\/doi.org\/10.3390\/ijms24108609   (2023).","DOI":"10.3390\/ijms24108609"},{"key":"84704_CR71","doi-asserted-by":"publisher","first-page":"105145","DOI":"10.1016\/j.isci.2022.105145","volume":"25","author":"N Zang","year":"2022","unstructured":"Zang, N. et al. cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. iScience 25, 105145. https:\/\/doi.org\/10.1016\/j.isci.2022.105145 (2022).","journal-title":"iScience"},{"key":"84704_CR72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou, Y. et al. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell. Death Dis. 12, 523. https:\/\/doi.org\/10\/gk3xqk (2021).","journal-title":"Cell. Death Dis."},{"key":"84704_CR73","doi-asserted-by":"publisher","first-page":"108711","DOI":"10.1016\/j.intimp.2022.108711","volume":"107","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS\/NLRP3 signaling pathway in diabetic kidney injury model. Int. Immunopharmacol. 107, 108711 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"84704_CR74","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10565-023-09790-0","volume":"39","author":"G Li","year":"2023","unstructured":"Li, G. et al. Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathway. Cell. Biol. Toxicol. 39, 621\u2013639. https:\/\/doi.org\/10.1007\/s10565-023-09790-0 (2023).","journal-title":"Cell. Biol. Toxicol."},{"key":"84704_CR75","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jcp.22362","volume":"226","author":"S Wu","year":"2011","unstructured":"Wu, S. et al. Bax is essential for DRP1-mediated mitochondrial fission but not for mitochondrial outer membrane permeabilization caused by photodynamic therapy. J. Cell. Physiol. 226, 530\u2013541. https:\/\/doi.org\/10.1002\/jcp.22362 (2011).","journal-title":"J. Cell. Physiol."},{"key":"84704_CR76","doi-asserted-by":"publisher","first-page":"100613","DOI":"10.1016\/j.bj.2023.100613","volume":"47","author":"CC Yang","year":"2023","unstructured":"Yang, C. C. et al. Repeated administration of adipose-derived mesenchymal stem cells added on beneficial effects of empagliflozin on protecting renal function in diabetic kidney disease rat. Biomed. J. 47, 100613. https:\/\/doi.org\/10.1016\/j.bj.2023.100613 (2023).","journal-title":"Biomed. J."},{"key":"84704_CR77","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13287-022-02857-5","volume":"13","author":"Y Yue","year":"2022","unstructured":"Yue, Y. et al. Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat. Stem Cell. Res. Ther. 13, 186. https:\/\/doi.org\/10.1186\/s13287-022-02857-5 (2022).","journal-title":"Stem Cell. Res. Ther."},{"key":"84704_CR78","doi-asserted-by":"publisher","first-page":"113947","DOI":"10.1016\/j.biopha.2022.113947","volume":"156","author":"YP Lu","year":"2022","unstructured":"Lu, Y. P. et al. Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5\/6-nephrectomy. Biomed. Pharmacother. 156, 113947. https:\/\/doi.org\/10.1016\/j.biopha.2022.113947 (2022).","journal-title":"Biomed. Pharmacother"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84704-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:06:37Z","timestamp":1735949197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84704-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84704"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84704-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of competing interest"}},{"value":"All experiments involving animals have been approved by the Institutional Animal Care and Use Committee of Zhejiang Chinese Medical University (the approval number of ethics committee: IACUC-20240429-16). All animal procedures were adhered to internationally accepted standards for animal research, following the 3Rs principle. The ARRIVE guidelines were employed for reporting experiments involving live animals, promoting ethical research practices.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"435"}}